- Title
- FAT1 Gene Expression in Iranian Acute Lymphoid and Myeloid Leukemia Patients
- Creator
- Dehagi, Mohammadreza Ostadali; Rostami, Shahrbano; Shamshiri, Ahmadreza; Safari, Fatemeh; Hosseini, Reza Haji; Thorne, Rick F.; Ghavamzadeh, Ardeshir
- Relation
- International Journal of Hematology-Oncology and Stem Cell Research Vol. 17, Issue 2, p. 81-88
- Publisher Link
- http://dx.doi.org/10.18502/ijhoscr.v17i2.12644
- Publisher
- Tehran University of Medical Sciences
- Resource Type
- journal article
- Date
- 2023
- Description
- Background: FAT atypical cadherin 1 (FAT1) is a member of the cadherin superfamily whose loss or gain is associated with the initiation and/or progression of different cancers. FAT1 overexpression has been reported in hematological malignancies. This research intended to investigate FAT1 gene expression in adult Iranian acute leukemia patients, compared to normal mobilized peripheral blood CD34+ cells. Materials and Methods: The peripheral blast (peripheral blood mononuclear cells) cells of 22 acute myeloid leukemia (AML), 14 acute lymphoid leukemia (ALL) patients, and mobilized peripheral blood CD34+ cells of 12 healthy volunteer stem cell donors were collected. Then, quantitative real-time polymerase chain reaction (qPCR) was used to compare FAT1 gene expression. Results: Overall, there were no significant differences in FAT1 expression between AML and ALL patients (p>0.2). Nonetheless, the mean expression level of FAT1 was significantly higher in leukemic patients (AML and ALL) than in normal CD34+ cells (p=0.029). Additionally, the FAT1 expression levels were significantly higher in both CD34+ and CD34-leukemic patients than in normal CD34+ cells (p=0.028). Conclusion: No significant differences were found between FAT1 expression in CD34+ and CD34-leukemic samples (p> 0.3). Thus, higher FAT1 expression was evident in ALL and AML leukemia cells but this appeared unrelated to CD34 expression. This suggests in a proportion of adult acute leukemia, FAT1 expression may prove to be a suitable target for therapeutic strategies.
- Subject
- FAT1; cadherin; acute myeloid leukemia (AML); acute lymphoid leukemia (ALL); leukemia; SDG 3; Sustainable Development Goals
- Identifier
- http://hdl.handle.net/1959.13/1483988
- Identifier
- uon:51247
- Identifier
- ISSN:1735-1243
- Language
- eng
- Hits: 1504
- Visitors: 1504
- Downloads: 0
| Thumbnail | File | Description | Size | Format |
|---|